More on athenahealth (ATHN): Q3 beats on the bottom line but comes up short on revenue...

|By:, SA News Editor

More on athenahealth (ATHN): Q3 beats on the bottom line but comes up short on revenue expectations. Total sales actually grew 26% Y/Y however, on solid sales growth among all its product lines. The company also guides lower for the year, now saying it sees FY12 revenue at the low end of previous guidance, and EPS at the high end Shares -1.4% AH.